Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ContextLogic Inc. - Class A Common Stock (NQ: LOGC ) 5.350 +0.030 (+0.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about ContextLogic Inc. - Class A Common Stock ContextLogic Inc. Reports Second-Quarter Financial Results August 08, 2024 From ContextLogic Inc. Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), October 31, 2022 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), Coffee Holding Co., Inc. (Nasdaq – JVA) October 20, 2022 From Brodsky & Smith LLC Via GlobeNewswire LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC October 18, 2022 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) CarLotz, Inc. (Nasdaq – LOTZ), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA) October 07, 2022 From Brodsky & Smith LLC Via GlobeNewswire LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC October 04, 2022 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA), BTRS Holdings Inc. (Nasdaq – October 03, 2022 From Brodsky & Smith LLC Via GlobeNewswire LOGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LogicBio Therapeutics, Inc. Is Fair to Shareholders October 03, 2022 From Halper Sadeh LLC Via Business Wire Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine October 03, 2022 From Alexion Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.